Home
Conditions
Adenocarcinoma of the Colon

Clinical trial condition

Adenocarcinoma of the Colon

Explore clinical trials studying Adenocarcinoma of the Colon. Study availability and eligibility vary by location and protocol.

26 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma of the Colon trial results

Completed

Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer

NCT01455831

Conditions: Adenocarcinoma of the Colon, Colonic Diseases, Colonic Neoplasms, +9 more
Locations: Ghent University Hospital Ghent, Belgium

Health Sciences North Greater Sudbury, Ontario, Canada

Hamilton Health Sciences Corporation Hamilton, Ontario, Canada

Kingston General Hospital Kingston, Ontario, Canada

View all 16 locations

View Trial Details

Completed

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

NCT01037790

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

NCT00397384

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

NCT01294826

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +16 more
Locations: Swedish Medical Center Cancer Institute Seattle, Washington, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer

NCT00032110

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +16 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

NCT00551421

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +18 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery

NCT00433576

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +18 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment

NCT00942266

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +16 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Stage III Colon Cancer

NCT00003835

Conditions: Adenocarcinoma of the Colon, Colonic Diseases, Colonic Neoplasms, +10 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

NCT00026234

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +17 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Adenocarcinoma of the Colon

Adenocarcinoma of the Colon trial results

Related conditions